Sound Income Strategies, LLC Biogen Inc. Transaction History

Sound Income Strategies, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 10, 2024	BUY	$222.59 - $267.94 $8,903 - $10,717	40 New	40 $10,000
Q2 2021 Jul 13, 2021	SELL	$259.0 - $414.71 $10,101 - $16,173	-39 Closed	0 $0
Q1 2021 Apr 14, 2021	BUY	$242.95 - $284.63 $4,859 - $5,692	20 Added 105.26%	39 $10,000
Q3 2020 Oct 08, 2020	BUY	$264.77 - $305.71 $5,030 - $5,808	19 New	19 $5,000
Q1 2019 Apr 04, 2019	SELL	$216.71 - $338.96 $4,334 - $6,779	-20 Closed	0 $0
Q3 2018 Oct 03, 2018	BUY	$293.51 - $383.83 $5,576 - $7,292	19 Added 1900.0%	20 $7,000
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $257 - $306	1 New	1 $0

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Sound Income Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Sound Income Strategies, LLC with notifications on news.